NEW YORK, Nov. 9 – IBM is partnering with the Department of Energy's National Nuclear Security Agency to develop Blue Gene/L, a 200-teraflop supercomputer that expands on the computer giant’s Blue Gene research project, the company announced on Friday. 

IBM and NNSA's Lawrence Livermore National Laboratory will jointly design Blue Gene/L, which IBM said will be 15 times faster, 15 times more power efficient, and will require about 50 times less space per computation than today's fastest supercomputers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.